• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:段舟萍,刘红,方鑫,魏筱华,周健.118例癫痫患者卡马西平血药浓度监测结果及影响因素分析[J].药学研究,2020,39(7):427-429[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2424次   下载 2476次 本文二维码信息
码上扫一扫!
118例癫痫患者卡马西平血药浓度监测结果及影响因素分析
段舟萍1,刘红2,方鑫1,魏筱华1,周健1
字体:加大+|默认|缩小-
(1.南昌大学第一附属医院,江西 南昌 330006;2.南昌大学研究生院医学部,江西 南昌 330006)
摘要:
目的 探讨癫痫患者卡马西平(CBZ)血药浓度的影响因素,为临床合理使用提供依据。方法 选取118例规律服用卡马西平治疗的癫痫患者作为研究对象,采用高效液相色谱法(HPLC)进行血药浓度监测,分析影响卡马西平血药浓度的因素。结果 75.42%的患者服用卡马西平后血药浓度控制在4~12 μg·mL-1之间;性别因素、年龄因素对卡马西平血药浓度的影响不明显(P>0.05);联合其他抗癫痫药时,无效浓度比例较高,具有统计学差异(P<0.05)。结论 服用卡马西平后,患者卡马西平血药浓度的个体差异大,尤其是合并使用其他癫痫药者。因此应避免联合使用,并积极监测患者药物浓度,实施个体化给药,促进安全合理使用。
关键词:  卡马西平  血药浓度  治疗药物监测  合理使用
DOI:10.13506/j.cnki.jpr.2020.07.014
基金项目:江西省科技厅重大支撑项目(No.20141BBG70018);江西省卫生计生委科技计划(No.20175080)
Monitoring results of Carbamazepine blood concentration in 118 epilepsy patients and analysis of influencing factors
DUAN Zhouping1,LIU Hong2,FANG Xin1,WEI Xiaohua1,ZHOU Jian1
(1.The First Affiliated Hospital of Nanchang University,Nanchang 330006,China;2.Nanchang University,Nanchang 330006,China)
Abstract:
Objective To investigate the factors that were affected concentration of Carbamazepine, provide foundation for clinical rational use.Methods 118 epileptic patients who regularly took CBZ were selected as study subjects.The blood concentration of was detected by high performance liquid chromatography (HPLC), we analyzed the factors which were affecting the blood concentration of carbamazepine.Results The concentration of 75.42% patients was between 4 and 12 μg·mL-1. Gender and age had no significant effect on blood concentration of CBZ (P>0.05). When combined with other antiepileptics, the proportion of ineffective concentration was higher, had significant effect on blood concentration of CBZ (P<0.05).Conclusion There was a great difference in CBZ blood concentration among patients who was taking CBZ, especially among those patients who was using other epilepsy drugs at the same time. Therefore, combination should be avoided, drug concentration should be actively monitored, so as to promote safty use.
Key words:  Carbamazepine  Plasma concentration  Therapeutic drug monitoring(TDM)  Rational use
今日访问量:2329    总访问量:55338697
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司